هفته نامه اطلاع رسانی اختراعات منتشر شده در سازمان جهانی مالکیت فکری
invbazaar.com

سالهفتهIDTitleApplNoIPCApplicantSubgroupزیر گروهرشته شرحDescription
202549WO/2024/254352SGLT1 INHIBITOR AND INCRETIN COMBINATIONS FOR TREATING METABOLIC DISEASEUS2024/032875C07D 233/70VOGENXCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/003545DERIVATIVES OF IMIDAZO[1,2-A]PYRIDINE WITH ANTI-INFLAMMATORY ACTIVITYES2024/070403C07D 471/04UNIVERSITAT DE VALÈNCIACHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/011618SALT OF THIAZOLOPYRAZINE COMPOUND OR CRYSTAL THEREOF AND USE THEREOFCN2024/104980C07D 513/04NANJING ZAIMING PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/176104HETEROCYCLIC DERIVATIVES HAVING S1P3 RECEPTOR ANTAGONISTIC ACTIVITYCN2025/077757C07D 401/14ONO PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/217205SYNTHESIS OF (-)-TRANS-Δ9-TETRAHYDROCANNABIVARIN (Δ9-THCV) AND ANALOGS THEREOFUS2025/023726C07D 311/80NALU BIO, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/226822POLYFORMS AND SALTS OF A 1,6-NAPHTHYRIDINE COMPOUND AND THEIR USE FOR THE TREATMENT OF CANCERUS2025/025980C07D 471/04BLACK DIAMOND THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/245591COMPOUNDS, PROCESS FOR OBTAINING THE COMPOUNDS, INTERMEDIATE COMPOUNDS, REAGENT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, PHARMACEUTICAL COMBINATIONS, MEDICAMENTS, USES AND METHODS OF TREATMENTBR2024/050227C07D 403/12ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/245600MULTI-TARGET COMPOUNDS, PROCESS FOR THE PREPARATION OF THE COMPOUNDS, INTERMEDIATES, PHARMACEUTICAL COMPOSITION, PHARMACEUTICALLY ACCEPTABLE SALTS, COMBINATION, MEDICAMENT, USE OF A COMPOUND AND METHOD OF TREATMENTBR2025/050203C07D 309/10ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/245601COMPOUNDS, PROCESS FOR OBTAINING THE COMPOUNDS, INTERMEDIATE COMPOUNDS, REAGENT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, PHARMACEUTICAL COMBINATIONS, MEDICAMENTS, USES AND METHODS OF TREATMENTBR2025/050205C07D 403/12ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/245656CRYSTALLINE SOLID FORMS OF SODIUM CHANNEL BLOCKERSCN2024/095465C07D 211/26LIBERTAS BIO, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/245928CHEMICAL SYNTHESIS METHOD FOR 10,11-DIBROMO-5H-DIBENZO[B,F]AZEPINE-5-CARBONYL CHLORIDECN2024/099503C07D 223/22ZHEJIANG RAYBOW PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/246177FAP-TARGETING DIMERIC COMPOUND, PROBE THEREOF, AND USE THEREOFCN2024/129937C07D 401/14CHINA PHARMACEUTICAL UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/246560PYRROLO[3,2-B]PYRIDINE TOP/HDAC DOUBLE-TARGET INHIBITOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOFCN2025/083368C07D 471/04NANJING HONGSHUN PHARMACEUTICAL TECHNOLOGY CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/246841KEY INTERMEDIATE OF LEMBOREXANT AND SYNTHESIS METHOD THEREFORCN2025/093443C07D 239/34CHANGZHOU NO.4 PHARMACEUTICAL FACTORY CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/246991COMPOUND, ORGANIC HOLE TRANSPORT LAYER MATERIAL, AND PEROVSKITE SOLAR CELLCN2025/095709C07D 498/06CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY, CHINESE ACADEMY OF SCIENCECHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247057PREPARATION METHOD FOR CHIRAL R- OR S-3-METHYLMORPHOLINECN2025/096412C07D 265/30SHANGHAI BALMXY PHARMACEUTIC CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247067KIF18A INHIBITORCN2025/096505C07D 401/14SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT, CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247149SALT OF CYP11A1 INHIBITOR AND CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOFCN2025/097135C07D 405/06LIAONING HAISCO PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247153NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOFCN2025/097172C07D 519/00SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247158PRODUCTION METHOD FOR HIGH-PURITY POLYMERIZATION-GRADE SUCCINIC ANHYDRIDECN2025/097201C07D 307/60SHANGHAI DIYANG CHEMICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247160HONOKIOL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOFCN2025/097213C07D 211/58SHANGHAI ZHIRUI XINCHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247178PRMT5 INHIBITOR, AND COMPOSITION AND USE THEREOFCN2025/097306C07D 487/04ALICORN PHARMACEUTICAL CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247226COMPOUND COMPRISING FUSED HETEROAROMATIC RING, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOFCN2025/097518C07D 471/04CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247243NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOFCN2025/097596C07D 413/14TONGJI UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247285PREPARATION METHOD FOR HETEROCYCLIC COMPOUND CAPABLE OF INHIBITING IL-17A, AND USE THEREOFCN2025/097821C07D 401/04XIZANG HAISCO PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247293NITRIC OXIDE DONOR-TYPE COMPOUND AND USE THEREOFCN2025/097865C07D 401/12OCUSUN OPHTHALMIC PHARMACEUTICAL (GUANGZHOU) CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247302CAMPTOTHECIN COMPOUND AND USE THEREOFCN2025/097909C07D 491/22HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247335COMPOUNDS AND USE THEREOF AS WRN INHIBITORSCN2025/098098C07D 471/14ALLORION THERAPEUTICS INCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247337TRICYCLIC FUSED COMPOUND, AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOFCN2025/098110C07D 471/04JING MEDICINE TECHNOLOGY LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247338PYRIDAZINE RING COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOFCN2025/098114C07D 487/04NEUSHEN THERAPEUTICS (SHANGHAI) CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247351LIGHT-EMITTING MATERIAL, DISPLAY PANEL, AND DISPLAY APPARATUSCN2025/098185C07D 491/107BOE TECHNOLOGY GROUP CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247352CRYSTAL FORM, SALT FORM, SOLVATE, HYDRATE OF COMPOUND AND USE THEREOFCN2025/098195C07D 471/04SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247353COMPOUND AND MEDICAL USE THEREOFCN2025/098196C07D 311/96SIGNET THERAPEUTICS INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247355MACROCYCLIC EGFR DEGRADER COMPOUND AND USE THEREOFCN2025/098204C07D 498/22SHANGHAI XIANXIANG MEDICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247357CLASS OF CD73 INHIBITORS WITH OXOAROMATIC HETEROCYCLIC STRUCTURE, PREPARATION METHODS THEREFOR, PHARMACEUTICAL COMPOSITIONS THEREOF, AND USE THEREOFCN2025/098222C07D 403/14INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCICENCESCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247360SALT OF KRAS G12D DEGRADATION AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOFCN2025/098247C07D 519/00RISEN (SUZHOU) PHARMA TECH CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247364HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOFCN2025/098289C07D 405/14SHANDONG SIMCERE BIOPHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247370BICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOFCN2025/098324C07D 231/56CHINA PHARMACEUTICAL UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247371PROTEIN DEGRADATION-TARGETING CHIMERA COMPOUNDS TARGETING BRAF, AND COMPOSITION AND USE THEREOFCN2025/098336C07D 401/14SHENZHEN TARGETRX, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247373FUSED RING COMPOUNDS AND THEIR USE AS WRN HELICASE INHIBITORSCN2025/098381C07D 471/04LAEKNA PHARMACEUTICAL NINGBO CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247379BENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOFCN2025/098426C07D 405/14SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247386N-ALKOXY ACETAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOFCN2025/098482C07D 403/04ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247390HETEROBICYCLIC COMPOUNDS USABLE AS GLP-1R AGONISTSCN2025/098519C07D 471/04FORTVITA BIOLOGICS INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247394NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOFCN2025/098569C07D 471/04NEUSHEN THERAPEUTICS (SHANGHAI) CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247396HETEROCYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOFCN2025/098585C07D 405/12BRISE PHARMACEUTICALS CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247401FUSED HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL USE THEREOFCN2025/098624C07D 487/18HAISCO PHARMACEUTICAL GROUP CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247411LACTAM PURIFICATION PROCESS METHOD AND PURIFICATION PROCESS DEVICECN2025/098895C07D 201/16CHINA TIANCHEN ENGINEERING CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247412PHENYLTHIAZOLAMINE PI4KIIIβ/HDAC DUAL-TARGET INHIBITOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOFCN2025/100070C07D 277/46NANJING HONGSHUN PHARMACEUTICAL TECHNOLOGY CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247515AMBERGRIS ISOMERS AND MIXTURES THEREOFEP2024/078969C07D 317/70SYMRISE AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247771NOVEL PROCESS FOR PREPARATION OF SUBSTITUTED 3-(3-PHENOXYPYRIDAZIN-4-YL)-5,6-DIHYDRO-4H-1,2,4- OXADIAZINESEP2025/064295C07D 413/04BAYER AKTIENGESELLSCHAFTCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247781SOLID FORM OF A QUINOLINE CARBOXAMIDE COMPOUNDEP2025/064383C07D 215/54SYNGENTA CROP PROTECTION AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247782SOLID FORM OF A QUINOLINE CARBOXAMIDE COMPOUNDEP2025/064384C07D 215/54SYNGENTA CROP PROTECTION AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247783PESTICIDALLY ACTIVE DIHYDRO-BENZOXAZINONE COMPOUNDSEP2025/064385C07D 265/36SYNGENTA CROP PROTECTION AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247785CRYSTALLINE SALT OF MACROPA-(OCH2CH2)-PH-NCSEP2025/064390C07D 413/14BAYER AKTIENGESELLSCHAFTCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247941PROCESS FOR PRODUCING A SOLID/LIQUID EXTRACTION SOLVENTEP2025/064721C07D 307/06ECOXTRACTCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/2479492,6-DIHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE DERIVATIVES AS ANTI-MALARIAL AGENTSEP2025/064743C07D 471/04MMV MEDICINES FOR MALARIA VENTURECHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247950METHOD FOR CONTROLLING A CAPROLACTAM CRYSTALLIZATION PROCESSEP2025/064745C07D 201/16BASF SECHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/247982PIPERAZINES WHICH ACT AS SSTR4 MODULATORSEP2025/064805C07D 403/12GRÜNENTHAL GMBHCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248032PESTICIDALLY ACTIVE INDAZOLE COMPOUNDSEP2025/064886C07D 231/56SYNGENTA CROP PROTECTION AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248073THERAPEUTIC COMPOUNDSEP2025/064959C07D 401/06SANOFICHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/2481176-AMINOPURINE DERIVATIVES USEFUL AS POLQ INHIBITORSEP2025/065047C07D 471/04ASTRAZENECA ABCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/2481196-(CYCLO)ALKOXYPURINE DERIVATIVES USEFUL AS POLQ INHIBITORSEP2025/065051C07D 473/30ASTRAZENECA ABCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248390PROCESS FOR THE PREPARATION OF THIOPHENE COMPOUNDSIB2025/055302C07D 333/38UPL LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248435TWO-STEP THERMAL PROCESS TO CONTROL THE FORMATION OF FURFURAL FROM THE CONVERSION OF PENTOSES OR PENTOSAN-RICH LIGNOCELLULOSIC BIOMASS USING ALCOHOLIC-ACID EUTECTIC MIXTURESIB2025/055444C07D 307/48UNIVERSIDADE DE AVEIROCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248450H2S-RELEASING MESALAMINE ANALOGSIB2025/055474C07D 267/14ANTIBE THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248483NR2F6 INHIBITOR AND USES THEREOFIB2025/055558C07D 405/12SAMJIN PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248535NOVEL SPIROCYCLIC COMPOUNDS TO TREAT VIRAL INFECTIONSIN2024/051915C07D 471/10ZYDUS LIFESCIENCES LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248536NOVEL OXIME DERIVATIVES TO TREAT VIRAL INFECTIONSIN2024/051916C07D 471/02ZYDUS LIFESCIENCES LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/248555AN IMPROVED PROCESS FOR THE PREPARATION OF DAPRODUSTAT AND ITS PHARMACEUTICALLY ACCEPTABLE SALTSIN2025/050803C07D 239/62DASHA PHARMACEUTICALS PRIVATE LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249120ORGANIC COMPOUND, ORGANIC IONIC COMPOUND, POLYMERIZATION INITIATOR, PHOTOBASE GENERATOR, AND PHOTOSENSITIVE COMPOSITIONJP2025/016974C07D 307/40DAITO CHEMIX CORPORATIONCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249409COMPOUND USEFUL AS ACTIVE INGREDIENT OF THERAPEUTIC AGENT FOR MYELIN SHEATH ABNORMALITY-RELATED DISEASEJP2025/019047C07D 207/12FUJITA ACADEMYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249507ENAMIDE COMPOUND AND PEST CONTROL AGENTJP2025/019437C07D 413/12NISSAN CHEMICAL CORPORATIONCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/2495403-AZABICYCLOHEXANE COMPOUND, AGRICULTURAL AND HORTICULTURAL HERBICIDE CONTAINING COMPOUND, AND METHOD FOR USING SAMEJP2025/019608C07D 209/52NIHON NOHYAKU CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249545SPIROCHROMANE COMPOUNDJP2025/019625C07D 491/107KISSEI PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249575COMPOUND EMITTING LIGHT UNDER SPECIFIC CONDITION, AND METHOD FOR DETECTING BIOLOGICAL ACTIVITY USING SAID COMPOUNDJP2025/019753C07D 513/04KYOTO UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249766COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAMEKR2025/005474C07D 307/77LG CHEM, LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249897NOVEL SULFAMIDE CAMPTOTHECIN DERIVATIVES WITH ANTITUMOR ACTIVITYKR2025/007240C07D 491/22HANMI PHARM. CO. LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249944THERMAL SHOCK PROTEIN-REGULATING CONJUGATE AND USE THEREOFKR2025/007411C07D 471/04MAGICBULLETTHERAPEUTICS CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/249975COMPOUND FOR DETECTING AMYLOID-BETA OLIGOMER AND METHOD FOR DIAGNOSING DEGENERATIVE BRAIN DISEASE USING SAMEKR2025/007502C07D 471/04AMYLOID SOLUTION INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250545AKT1 MODULATORSUS2025/031050C07D 498/04ALTEROME THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250553SOLID STATE FORMS OF IMIPRIDONE DERIVATIVEUS2025/031060C07D 471/14CHIMERIX, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250620TRICYCLIC FUSED WRN INHIBITORSUS2025/031170C07D 487/14NIMBUS WADJET, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250632BERBERINE ALPHA-KETOGLUTARATE SALT, CRYSTALLINE FORM, METHODS OF PREPARATION AND APPLICATIONS THEREOFUS2025/031187C07D 491/147LONGEVITAN BIOSCIENCES LLCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250650CRYSTALLINE FORMS OF N-(1-(TERT-BUTYL)-1H-PYRAZOL-4-YL)-2-(4-((6-((METHYLSULFONYL)QUINOLIN-4-YL)OXY)-3-METHYLPHENYL)ACETAMIDE AND SALTS THEREOF AS RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASESUS2025/031212C07D 401/12ODYSSEY THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250667N-(1-(TERT-BUTYL)-1 H-PYRAZOL-4-YL)-2-(4-((6-(QUINOLIN-4-YL)OXY)-PHENYL)ACET AMIDE DERIVATIVES AS RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASESUS2025/031234C07D 401/12ODYSSEY THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250729LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOFUS2025/031327C07D 205/04LIBERATE BIO, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250730LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOFUS2025/031328C07D 211/22LIBERATE BIO, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250828METHOD FOR PREPARING BERAPROST 314-D SODIUMUS2025/031486C07D 307/91YS LIFE SCIENCE CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250930HDAC6 INHIBITORS AND METHOD OF THEIR USEUS2025/031639C07D 239/24BAERENKRAFT THERAPEUTICS, LLC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/250945PIM INHIBITORS AND METHOD OF THEIR USEUS2025/031665C07D 401/04BAERENKRAFT THERAPEUTICS, LLC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202549WO/2025/251010IMIDAZOLES ARE TUNABLE NUCLEOFUGES FOR DEVELOPING TYROSINE-REACTIVE ELECTROPHILESUS2025/031755C07D 233/84UNIVERSITY OF VIRGINIA PATENT FOUNDATIONCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی